McKesson Corporation $MCK Stock Acquired by Ellsworth Advisors LLC

Ellsworth Advisors LLC grew its position in shares of McKesson Corporation (NYSE:MCK) by 1,477.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,909 shares of the company’s stock after purchasing an additional 6,471 shares during the quarter. Ellsworth Advisors LLC’s holdings in McKesson were worth $5,899,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Rosenberg Matthew Hamilton grew its position in McKesson by 2.8% during the third quarter. Rosenberg Matthew Hamilton now owns 406 shares of the company’s stock valued at $347,000 after buying an additional 11 shares during the period. Anchyra Partners LLC increased its holdings in McKesson by 1.0% in the first quarter. Anchyra Partners LLC now owns 1,174 shares of the company’s stock valued at $1,016,000 after buying an additional 12 shares in the last quarter. SJS Investment Consulting Inc. increased its holdings in McKesson by 7.5% in the first quarter. SJS Investment Consulting Inc. now owns 172 shares of the company’s stock valued at $149,000 after buying an additional 12 shares in the last quarter. SMART Wealth LLC raised its position in shares of McKesson by 3.4% in the first quarter. SMART Wealth LLC now owns 366 shares of the company’s stock worth $317,000 after acquiring an additional 12 shares during the period. Finally, Stephens Inc. AR raised its position in shares of McKesson by 0.8% in the first quarter. Stephens Inc. AR now owns 1,581 shares of the company’s stock worth $1,368,000 after acquiring an additional 12 shares during the period. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Leerink raised its price target to $1,070, implying additional upside from recent levels and reinforcing the bullish analyst outlook. Leerink lifts target for McKesson stock to USD 1,070
• Positive Sentiment: Jim Cramer called McKesson a health-care “winner,” adding favorable high-profile commentary as the stock continues to outperform the broader market. Jim Cramer: This Health Care Stock Is A Winner
• Positive Sentiment: McKesson approached $1,000 after setting a fresh 52-week high near $998.64, signaling strong momentum and sustained demand for the shares. McKesson Approaches $1,000 After Setting a New 52-Week High
• Positive Sentiment: Separate coverage reported an all-time high around $1,000.97, while another report highlighted a $1.4 billion McKesson commitment, adding to the company’s favorable news flow. McKesson stock hits all-time high
• Neutral Sentiment: The rally follows McKesson’s latest quarterly results, which exceeded EPS and revenue expectations and showed 7.7% year-over-year revenue growth. However, the stock is near its 12-month high, which may increase sensitivity to profit-taking.

McKesson Stock Up 2.1%

MCK stock opened at $997.40 on Friday. The stock has a market capitalization of $116.29 billion, a P/E ratio of 26.69, a P/E/G ratio of 1.94 and a beta of 0.30. The firm has a 50-day simple moving average of $894.99 and a 200-day simple moving average of $836.32. McKesson Corporation has a 52 week low of $723.68 and a 52 week high of $1,003.21.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, topping the consensus estimate of $9.56 by $0.37. The firm had revenue of $105.38 billion during the quarter, compared to the consensus estimate of $103.88 billion. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $8.26 EPS. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, analysts expect that McKesson Corporation will post 44.71 earnings per share for the current year.

McKesson Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st were paid a $0.94 dividend. This is a boost from McKesson’s previous quarterly dividend of $0.82. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Tuesday, September 1st. McKesson’s dividend payout ratio is presently 10.06%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on MCK. Evercore reissued an “outperform” rating and set a $950.00 target price (down from $1,000.00) on shares of McKesson in a research note on Thursday, August 6th. Robert W. Baird set a $1,015.00 target price on McKesson in a research report on Thursday, August 6th. Citigroup lifted their price target on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Mizuho upped their price target on McKesson from $885.00 to $905.00 in a report on Thursday, August 6th. Finally, Wall Street Zen cut McKesson from a “buy” rating to a “hold” rating in a report on Saturday, June 27th. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, McKesson has an average rating of “Moderate Buy” and a consensus target price of $983.29.

Insider Activity at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the firm’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total value of $98,950.95. Following the transaction, the chief accounting officer owned 521 shares in the company, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of the firm’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. Additional details regarding this sale are available in the official SEC disclosure. 0.06% of the stock is currently owned by insiders.

McKesson Profile

McKesson Corporation (NYSE:MCK) is a healthcare services and information technology company that distributes pharmaceuticals, specialty drugs, medical supplies and other healthcare products. The company serves pharmacies, hospitals, health systems, physician practices, biopharma manufacturers and other healthcare providers, helping move products from manufacturers to patients and care settings.

McKesson’s principal operations include pharmaceutical distribution, medical-surgical supply distribution and technology-enabled services for pharmacies and providers.